EverHint – Momentum Swing — Explosive Volume Breakout for Apr 13, 2026 – 2 Signals – Technology Leads (1)

2 signals. Technology leads (1). 2 with insider selling. price range $63-$128. sectors: Technology (1), Healthcare (1). full analyst coverage, earnings data.

What This Signal Is (Quick)

Explosive Volume Breakout is a momentum swing trading strategy focused on Breakouts with 2.5x+ volume surge - institutional buying pressure.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

  • Stock showing strong momentum near or at highs
  • Increased volume confirms institutional interest
  • Breaking out or consolidating near resistance
  • Breakouts with 2.5x+ volume surge - institutional buying pressure

Ideal For: Traders seeking breakouts with exceptional volume confirmation

Key Criteria:

  • Strong RSI momentum (configurable thresholds)

  • Volume surge above average

  • Price momentum confirmation

  • Minimum ADV: $25M+ (varies by variant)

  • Earnings buffer: 7 days pre/post earnings

  • Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High


How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)


📊 Momentum Swing — Explosive Volume Breakout Signals (2 Total)

Ranked by score:

Rank Ticker Company Sector Last ($) Score Vol Thrust @52w Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 FORM FormFactor, Inc. Technology 128.22 0.300 2.73x 0.0% $-472K 15 $0.00 10.0
2 SYRE Spyre Therapeutics, Inc. Healthcare 63.27 0.000 5.21x 0.0% $-1.5M 23 $-3.74 3.8

Field Notes

Sector concentration: Technology (1), Healthcare (1)

Insider selling: SYRE (Spyre Therapeutics, Inc., $-1.5M), FORM (FormFactor, Inc., $-472K)

Data coverage: 100.0% insider, 0.0% congressional, 100.0% earnings, 100.0% analyst, 0.0% news


Peer Analysis

Understanding how these stocks relate to their industry peers:

FORM (FormFactor, Inc.): Leads 10 peers: SLAB ($211.32, +0.1%), AMBA ($54.30, +2.9%), IPGP ($127.32), SIMO ($126.00, -0.6%), VICR ($186.22, +0.3%) | Peer of: ALGM ($38.04, +1.4%), AMBA ($54.30, +2.9%), AVGO ($379.75, +2.2%) and 4 more

SYRE (Spyre Therapeutics, Inc.): Leads 10 peers: PHVS ($27.88, +4.7%), IMNM ($22.62, +4.3%), WVE ($7.26, +1.1%), NTLA ($14.26, +5.7%), ZYME ($26.17, -0.6%) | Peer of: ABCL ($3.66, +3.4%), ARDX ($6.33, +2.4%), AZTA ($23.33, +5.0%) and 12 more


Market Context

Broad market indices are exhibiting solid upward momentum, with technology-heavy benchmarks leading gains at over 1% while broader measures like the S&P 500 and Dow Jones post more modest advances around 0.6-1%. This risk-on environment signals healthy investor appetite, favoring momentum swing strategies that thrive on sustained directional moves. The VIX's decline to 19.03 reflects contracting volatility, reducing the likelihood of sharp intraday reversals and creating a more favorable setup for explosive volume breakouts, where clear trends can develop without excessive noise.

Lower volatility levels enhance the reliability of swing trades by minimizing whipsaws, allowing breakouts to gain traction amid positive trend alignment. With risk appetite elevated, as evidenced by outperformance in growth-oriented sectors, these conditions amplify the potential for high-conviction signals, particularly in leading areas like technology. Traders should monitor for sustained volume confirmation to capitalize on this setup.

Sector rotation dynamics underscore technology's dominance, drawing capital flows that bolster breakout opportunities within high-momentum names. This rotation away from more defensive areas supports the strategy's emphasis on explosive moves, though participants must remain vigilant for any VIX spikes that could erode intraday swing potential.

Sharing Call-to-Action

🔍 If this breakdown was useful, feel free to like, share, or subscribe. Every bit of support matters.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/